A

Anaptysbio (ANAB)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Anaptysbio (ANAB)

AnaptysBio, Inc. is a clinical stage biotechnology company. The Company is developing immunology therapeutic product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops its ... Read more

Open
USD26.93
High
USD27.22
Low
USD26.12
52 Week High
USD41.31
Monthly Return
15.60%
Revenue
112M

Daily Vol.
426.94k
Avg. Daily Vol.
657.70k
Market Cap.
770M
52 Week Low
12.21
Annual Return
-10.50%

Stock News

S&P 500 stumbles after hitting intraday high — the downside of a narrow rally

S&P 500 stumbles after hitting intraday high — the downside of a narrow rally

MarketWatch

Amazon turns to rival SpaceX to launch next batch of Kuiper internet satellites

Amazon turns to rival SpaceX to launch next batch of Kuiper internet satellites

CNBC

GM expands production of gas-powered SUV, trucks in Michigan

GM expands production of gas-powered SUV, trucks in Michigan

CNBC

Trump's new trade deal promises billions to the U.S. — plus, reasons behind the mixed market

Trump's new trade deal promises billions to the U.S. — plus, reasons behind the mixed market

CNBC

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.